序号 |
标题 |
次数 |
作者 |
发布时间 |
73216 |
Butyne-DOTA-tris(t-butyl ester),CAS: 2125661-54-1 |
146 |
h |
2024-12-16 |
73217 |
pAAV-PEG3-sTRAIL质粒 |
82 |
kx |
2024-12-16 |
73218 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
107 |
WYQ |
2024-12-16 |
73219 |
DOTA-PEG4-alkyne,CAS:2080307-47-5 |
66 |
h |
2024-12-16 |
73220 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
67 |
WYQ |
2024-12-16 |
73221 |
DOTA-NHS-ester,CAS:170908-81-3 |
58 |
h |
2024-12-16 |
73222 |
99Tcm-3PEG4-RGD |
99 |
kx |
2024-12-16 |
73223 |
Azido-PEG5-CH2CO2-t-Bu(CAS号:1448451-72-6) |
63 |
WYQ |
2024-12-16 |
73224 |
DOTA螯合剂DOTA-4AMP,CAS:254444-71-8 |
76 |
h |
2024-12-16 |
73225 |
Azido-PEG4-CH2CO2-t-Bu(CAS号:864681-04-9) |
64 |
WYQ |
2024-12-16 |
73226 |
alkoxyamine-PEG4-biotin ,烷氧基胺-四聚乙二醇-生物素 |
177 |
kx |
2024-12-16 |
73227 |
DOTA-CXCR4-L,DOTA-CXCR4靶向肽 |
102 |
h |
2024-12-16 |
73228 |
DOTA-Tetrazine,DOTA-四嗪 |
72 |
h |
2024-12-16 |
73229 |
Ag~(TS)-S(CH2)_(n-1)CH3// Ga2O3/EGaIn junctions,烷基链定制 |
135 |
wyh |
2024-12-16 |
73230 |
CMP-SA-PEG4-biotin的主要结构组成及功能 |
140 |
kx |
2024-12-16 |
73231 |
DOTA-Tetrazine,DOTA-四嗪 |
79 |
h |
2024-12-16 |
73232 |
Au25(SCH2CH2Ph)18,烷基链定制 |
96 |
wyh |
2024-12-16 |
73233 |
18F-AlF-NOTA-PEG4-ZD2 , 18F-AlF-1,4,7-三氮杂环壬烷-1,4,7-三乙酸-(聚乙二醇)4-ZD2 |
97 |
kx |
2024-12-16 |
73234 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
72 |
wyh |
2024-12-16 |
73235 |
Azido-PEG3-CH2CO2-t-Bu(CAS号:172531-36-1) |
97 |
WYQ |
2024-12-16 |
73236 |
mPEG113-b-P(MTC-Cholx-co-TMCy)x+y |
99 |
kx |
2024-12-16 |
73237 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
109 |
wyh |
2024-12-16 |
73238 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
79 |
WYQ |
2024-12-16 |
73239 |
DTPA(Gd)-PEG8-(FY)3 , DTPA(Gd)-聚乙二醇8-(FY)3 |
90 |
kx |
2024-12-16 |
73240 |
靶向CD45的抗体药物偶联物 |
105 |
kx |
2024-12-16 |
73241 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
70 |
WYQ |
2024-12-16 |
73242 |
抗体偶联药物的药物连接子MCMMAF |
93 |
kx |
2024-12-16 |
73243 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
59 |
WYQ |
2024-12-16 |
73244 |
全氟十四烷酸(PF;CF3(CF2)12COOH),烷基链定制 |
153 |
wyh |
2024-12-16 |
73245 |
靶向CD45的抗体药物偶联物 |
114 |
kx |
2024-12-16 |
73246 |
CH3(CH2)7COOH-CH3(CH2)7COO钠,烷基链定制 |
97 |
wyh |
2024-12-16 |
73247 |
HS(CH2)17CH3 ,十八硫醇,烷基链定制 |
132 |
wyh |
2024-12-16 |
73248 |
Fmoc-Val-Cit-PABC-Cn |
91 |
kx |
2024-12-16 |
73249 |
Mc-Val-Cit-PABOH ,组织蛋白酶B可切割 |
110 |
kx |
2024-12-16 |
73250 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
106 |
WYQ |
2024-12-16 |
73251 |
抗体偶联药物连接子Mc-Val-Cit-PABC-PNP |
104 |
kx |
2024-12-16 |
73252 |
NHS-d-PEG24-biotin |
132 |
kx |
2024-12-16 |
73253 |
β-agarase-BTPEG24-SA@MNPs , β-琼胶酶-生物素/链霉亲和素修饰的磁性纳米粒子 |
92 |
kx |
2024-12-16 |
73254 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
71 |
WYQ |
2024-12-16 |
73255 |
KYE28-PEG48 |
119 |
kx |
2024-12-16 |
73256 |
[(18)F]F-PEG(6)-IPQA PET示踪剂 |
114 |
kx |
2024-12-16 |
73257 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
82 |
WYQ |
2024-12-16 |
73258 |
HS-(CH2)17-CH3,1-十八硫醇,烷基链定制 |
80 |
wyh |
2024-12-16 |
73259 |
MePEG17-b-PCL5 ,甲氧基聚乙二醇-嵌段-聚己内酯 |
84 |
kx |
2024-12-16 |
73260 |
MAMA-(CH2)16COOH,烷基链定制 |
69 |
wyh |
2024-12-16 |